Alyeska Investment Group, L.P. Gh Research PLC Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Gh Research PLC stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 454,975 shares of GHRS stock, worth $6.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
454,975Holding current value
$6.6 Million% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding GHRS
# of Institutions
42Shares Held
38.5MCall Options Held
5KPut Options Held
5.5K-
Bvf Inc San Francisco, CA8.83MShares$128 Million4.28% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.94MShares$101 Million1.59% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.44MShares$93.4 Million26.28% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$79.7 Million0.99% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$29.1 Million2.35% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $754M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...